139 related articles for article (PubMed ID: 16533421)
61. Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression.
Semba S; Huebner K
Mol Cancer Res; 2006 Aug; 4(8):529-38. PubMed ID: 16885564
[TBL] [Abstract][Full Text] [Related]
62. Fhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel.
Gaudio E; Paduano F; Spizzo R; Ngankeu A; Zanesi N; Gaspari M; Ortuso F; Lovat F; Rock J; Hill GA; Kaou M; Cuda G; Aqeilan RI; Alcaro S; Croce CM; Trapasso F
PLoS One; 2013; 8(11):e78610. PubMed ID: 24223161
[TBL] [Abstract][Full Text] [Related]
63. Signaling Crosstalk of FHIT, p53, and p38 in etoposide-induced apoptosis in MCF-7 cells.
Khedri A; Khaghani S; Kheirollah A; Babaahmadi-Rezaei H; Shadboorestan A; Zangooei M; Afra HS; Meshkani R; Ghahremani MH
J Cell Biochem; 2019 Jun; 120(6):9125-9137. PubMed ID: 30614034
[TBL] [Abstract][Full Text] [Related]
64. Cypripedin, a phenanthrenequinone from Dendrobium densiflorum, sensitizes non-small cell lung cancer H460 cells to cisplatin-mediated apoptosis.
Wattanathamsan O; Treesuwan S; Sritularak B; Pongrakhananon V
J Nat Med; 2018 Mar; 72(2):503-513. PubMed ID: 29426985
[TBL] [Abstract][Full Text] [Related]
65. Investigation of mutations and expression of the FHIT gene in Turkish patients with brain metastases derived from non-small cell lung cancer.
Bekar A; Ceçener G; Tunca B; Guler G; Egeli U; Tolunay S
Tumori; 2007; 93(6):604-7. PubMed ID: 18338497
[TBL] [Abstract][Full Text] [Related]
66. Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 gene.
Inoue A; Narumi K; Matsubara N; Sugawara S; Saijo Y; Satoh K; Nukiwa T
Cancer Lett; 2000 Aug; 157(1):105-12. PubMed ID: 10893449
[TBL] [Abstract][Full Text] [Related]
67. Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant.
Ottey M; Han SY; Druck T; Barnoski BL; McCorkell KA; Croce CM; Raventos-Suarez C; Fairchild CR; Wang Y; Huebner K
Br J Cancer; 2004 Nov; 91(9):1669-77. PubMed ID: 15494723
[TBL] [Abstract][Full Text] [Related]
68. Influence of a nonfragile FHIT transgene on murine tumor susceptibility.
McCorkell KA; Mancini R; Siprashvili Z; Barnoski BL; Iliopoulos D; Siracusa LD; Zanesi N; Croce CM; Fong LY; Druck T; Huebner K
Cytogenet Genome Res; 2007; 118(2-4):196-203. PubMed ID: 18000371
[TBL] [Abstract][Full Text] [Related]
69. Influence of nonprotective autophagy and the autophagic switch on sensitivity to cisplatin in non-small cell lung cancer cells.
Patel NH; Xu J; Saleh T; Wu Y; Lima S; Gewirtz DA
Biochem Pharmacol; 2020 May; 175():113896. PubMed ID: 32135156
[TBL] [Abstract][Full Text] [Related]
70. X-ray irradiation altered chemosensitivity of a p53-null non-small cell lung cancer cell line.
Tsutsumi K; Yasuda M; Nishioka T
Cell Struct Funct; 2006; 31(2):47-52. PubMed ID: 16951535
[TBL] [Abstract][Full Text] [Related]
71. Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells.
Druck T; Cheung DG; Park D; Trapasso F; Pichiorri F; Gaspari M; Palumbo T; Aqeilan RI; Gaudio E; Okumura H; Iuliano R; Raso C; Green K; Huebner K; Croce CM
Cell Death Dis; 2019 Feb; 10(3):147. PubMed ID: 30770797
[TBL] [Abstract][Full Text] [Related]
72. Synthesis of Fluorescent Probes Targeting Tumor-Suppressor Protein FHIT and Identification of Apoptosis-Inducing FHIT Inhibitors.
Kawaguchi M; Sekimoto E; Ohta Y; Ieda N; Murakami T; Nakagawa H
J Med Chem; 2021 Jul; 64(13):9567-9576. PubMed ID: 34160227
[TBL] [Abstract][Full Text] [Related]
73. Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment.
Vural S; Simon R; Krushkal J
Hum Genomics; 2018 Apr; 12(1):20. PubMed ID: 29642934
[TBL] [Abstract][Full Text] [Related]
74. Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells.
Gupta S; Koru-Sengul T; Arnold SM; Devi GR; Mohiuddin M; Ahmed MM
Mol Cancer Ther; 2011 Feb; 10(2):292-302. PubMed ID: 21216938
[TBL] [Abstract][Full Text] [Related]
75. [The inhibition of fragile histidine triad gene on the proliferation and tumorigenicity of mucoepidermoid carcinoma cells].
Liu F; Wu JZ; Li F; Li Y; Li J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2008 Jun; 26(3):252-5. PubMed ID: 18705504
[TBL] [Abstract][Full Text] [Related]
76. Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding.
Trapasso F; Krakowiak A; Cesari R; Arkles J; Yendamuri S; Ishii H; Vecchione A; Kuroki T; Bieganowski P; Pace HC; Huebner K; Croce CM; Brenner C
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1592-7. PubMed ID: 12574506
[TBL] [Abstract][Full Text] [Related]
77. Antiproliferative and apoptotic activities of ketonucleosides and keto-C-glycosides against non-small-cell lung cancer cells with intrinsic drug resistance.
Paterson J; Uriel C; Egron MJ; Herscovici J; Antonakis K; Alaoui-Jamali MA
Antimicrob Agents Chemother; 1998 Apr; 42(4):779-84. PubMed ID: 9559782
[TBL] [Abstract][Full Text] [Related]
78. Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells.
Trapasso F; Pichiorri F; Gaspari M; Palumbo T; Aqeilan RI; Gaudio E; Okumura H; Iuliano R; Di Leva G; Fabbri M; Birk DE; Raso C; Green-Church K; Spagnoli LG; Venuta S; Huebner K; Croce CM
J Biol Chem; 2008 May; 283(20):13736-44. PubMed ID: 18319262
[TBL] [Abstract][Full Text] [Related]
79. N-Terminal Domain of Fragile Histidine Triad Exerts Potent Cytotoxic Effect in HT1080 Cells and Increases Doxorubicin Cytotoxicity.
Eslamparast A; Abbasgholizadeh R; Ostad SN; Gharghabi M; Ghahremani MH
Iran J Pharm Res; 2019; 18(1):254-262. PubMed ID: 31089360
[TBL] [Abstract][Full Text] [Related]
80. The effects of cetuximab and cisplatin anti-cancer drugs on the mechanical properties of the lung cancerous cells using atomic force microscope.
Rezaei I; Sadeghi A
Biochem Cell Biol; 2023 Dec; 101(6):531-537. PubMed ID: 37437307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
